Items tagged with Access
Treatment for drug-resistant TB now available in the Philippines (post)
The fight against drug-resistant tuberculosis in the country is set to get a boost with a new treatment now made available locally.
India: Much-delayed daily TB regimen to roll out by October (post)
The much-delayed daily regimen of tuberculosis will be rolled out by the government in a phased manner across the country by October this year. The rollout of the daily drug therapy, considered a game changer in the fight against tuberculosis by experts, doctors and activists, was to be piloted under the Revised National Tuberculosis Control Programme (RNTCP) in five states by March, after a delay of roughly two years.
Pakistan: Acute shortage of TB drugs prolongs (post)
June 13, 2016 - An acute shortage of tuberculosis (TB) drugs in Pakistan has now entered the seventh month and is adding to the misery of thousands of TB patients across the country, and posing serious risk of rapid rise in TB prevalence in Pakistan.
India: Assam first state to launch miracle TB medicine (post)
GUWAHATI, June 6 - Assam has become the first state of the country to launch the miracle drug bedaquiline – the first new medicine for TB in more than 40 years – for treatment of drug-resistant TB.
Bedaquiline: A new hope to MDR-TB patients in the Philippines (post)
The first new drug to treat tuberculosis in more than 40 years, Bedaquiline is helping patients fight multidrug-resistant tuberculosis (MDR-TB) through its donation program – a public-private partnership between United States Agency for International Development (USAID) and Janssen Therapeutics of Johnson & Johnson.
Panels brainstorm ideas on innovation and drug access (post)
The quest of balance between encouraging medical innovation and the imperative of broad access to medicines has so far been elusive. Two Harvard University programmes jointly organised a workshop this week with the aim of encouraging a conversation between global health actors and see if some “outside the box” thinking is possible.
UN development agency issues guidelines for pharmaceutical patent examiners (post)
A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products.
World Health Organization’s TB care advice violated standards, researchers say (post)
Durham, NC - The World Health Organization (WHO) violated sound standards of medical care and human rights by nudging poorer countries to follow less expensive, untested and largely ineffective treatment protocols for tuberculosis patients, a new paper by researchers at Duke, Brandeis and Harvard universities argues.
South Africa: Survey finds massive medicine shortages in clinics (post)
The public health system continues to have shortages of HIV and TB medicines, with nearly a quarter of clinics surveyed reporting stockouts in the past three months.
India: Daily drug TB treatment to begin in September (post)
The government is set to roll out the daily drug treatment for tuberculosis in Mumbai from September this year, replacing the three-times-a-week treatment schedule. The new treatment protocol for drug-sensitive cases — the regular TB cases that react to first line drugs — will be rolled out in five states including Maharashtra. The new protocol will eventually help bring down relapse rates, and in turn the number of drug-resistant TB cases.
Page 22 of 83 · Total posts: 0
←First 21 22 23 Last→